相关实验视频

Updated: Jul 19, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

[与造血干细胞移植相关的毛细血管泄漏综合征的研究进展--评论]

Chang Liu¹, Shao-Yan Hu²

¹Jiangsu Children's Hematology and Oncology Center; Department of Hematology, Children's Hospital of Soochow University, Suzhou 215003, Jiangsu Province, China.

Zhongguo shi yan xue ye xue za zhi

|August 8, 2023

概括

毛细血管泄漏综合征 (CLS) 是干细胞移植后的一种严重并发症,标志着血管泄漏. 本综述总结了它的原因,症状和当前的治疗方法.

科学领域:

血液学血液学血液学
免疫学免疫学免疫学
移植医学移植医学

背景情况:

毛细血管泄漏综合征 (CLS) 是血液造血干细胞移植 (HSCT) 后的一个关键并发症.
它的特点是血管内皮屏障功能受损,导致血管透率增加和全身.
确切的发病因子尚不清楚,高细胞动力和内皮细胞的超透性被认为是核心因素.

结论:

了解CLS的发病因子对于开发向疗法至关重要.
需要标准化的诊断标准和统一的CLS治疗方案.
进一步研究HSCT相关的CLS对于改善患者的治疗结果至关重要.

关键词:

毛细血管泄漏综合征是什么意思造血干细胞移植造血干细胞移植具有高透性的高透性.超细胞因子症的高细胞因子症治疗治疗治疗治疗治疗治疗

更多相关视频

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...